Clinical Trial: A Clinical Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Belumosudil in Chinese Adolescents With cGVHD Who Have Had an Inadequate Response to Glucocorticoids or Other Systemic Therapies
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Chronic Graft Versus Host Disease
Study Type: INTERVENTIONAL
Official Title: A Multicenter, Open-label, Single-arm, Phase 4 Clinical Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Belumosudil Mesylate Tablets in Chinese Adolescents (Aged From 12 to Less Than 1
Brief Summary:
This is a single group, Phase 4, single-arm post-marketing study for treatment.The purpose of this study is to verify the pharmacokinetics, efficacy, and safety of belumosudil mesylate tablets in Chinese adolescent participants (aged from 12 to less than 18) with cGVHD who have had an inadequate response to glucocorticoids or other systemic therapies.Participants will receive treatment with belumosudil tablets 200 mg once daily in 28-day cycles during the study.
Read more